Moreover, many studies showed that expression levels of FADS2 were positively correlated with non-alcoholic fatty liver disease, and down-regulated FADS2 may contribute to the maintaining the activity of delta-6 desaturase to ensure liver digestive function [109]. This evidence concerns the gene FADS2 and metabolic dysfunction-associated steatotic liver disease.